Related Experiment Video
Updated: Aug 9, 2025

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Child Neurology: Reversible Dementia in an 18-Year-Old Woman Due to Undiagnosed Cobalamin-G Deficiency: A Case Report
Anthony M Gacita1, Alma Bicknese1, Katherine Kim1
1From the Department of Genetics, Genomics, and Metabolism (A.M.G., K.K., J.B.), Department of Neurology (A.B.), and Department of Psychiatry and Behavioral Health (F.Z.), Ann & Robert H. Lurie Children's Hospital of Chicago, IL.
Insights
Cobalamin-G deficiency, a vitamin B12 metabolism disorder, can manifest later in life with dementia. Early diagnosis and treatment with B12 can reverse cognitive decline.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Cobalamin-G deficiency is an inherited metabolic disorder affecting vitamin B12 utilization in the remethylation pathway.
- Classic presentation involves early-onset anemia, developmental delay, and metabolic crisis.
Observation:
- A late-onset phenotype of Cobalamin-G deficiency was observed in an 18-year-old female.
- Symptoms included progressive dementia, encephalopathy, epilepsy, and functional regression over 4 years.
- Initial metabolic screening was normal.
Findings:
- Whole-exome sequencing revealed pathogenic variants in the MTR gene, suggesting Cobalamin-G deficiency.
- Subsequent biochemical testing confirmed the diagnosis.
- Treatment with leucovorin, betaine, and vitamin B12 injections led to cognitive recovery.
Implications:
- This case expands the known phenotypic spectrum of Cobalamin-G deficiency to include late-onset neuropsychiatric presentations.
- Highlights the importance of considering genetic and metabolic testing for dementia in adolescents.
- Suggests potential for therapeutic intervention even in later-presenting cases.
Abstract:
Cobalamin-G deficiency is an inborn error of metabolism which disrupts the biochemical utilization of vitamin B12 to covert homocysteine to methionine in the remethylation pathway. Typically, affected patients present within the first year of life with anemia, developmental delay, and metabolic crisis. Few case reports of cobalamin-G deficiency reference a later onset phenotype primarily defined by neuropsychiatric symptoms. We report an 18-year-old woman who presented with a 4-year history of progressively worsening dementia, encephalopathy, epilepsy, and regression of adaptive functioning, with an initially normal metabolic workup. Whole-exome sequencing identified variants in the MTR gene, suspicious for cobalamin-G deficiency. Additional biochemical testing after genetic testing supported this diagnosis. Since treatment with leucovorin, betaine, and B12 injections, we have seen a gradual return to normal cognitive function. This case report expands the phenotypic range of cobalamin-G deficiency and offers rationale for genetic and metabolic testing in cases of dementia in the second decade of life.
Related Concept Videos
Vitamins
Inborn Errors of Metabolism
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Treatment
Bulimia Nervosa

